HealthStream, Inc. — FY2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022; filed February 28, 2023. This is an annual report, not a standalone fourth-quarter report. Financial comparisons below are primarily with FY2021.
Business context
HealthStream provides subscription-based software and related services to healthcare organizations, including workforce learning, training, competency, scheduling, and provider credentialing, privileging, and enrollment tools. Its hStream platform supports the company’s single-platform strategy. At year-end, contracted hStream subscriptions were 5.54 million, up from 5.04 million a year earlier. In 2022, the company reported Workforce Solutions and Provider Solutions; from January 2023, it moved to one operating and reportable segment under its “One HealthStream” approach.
Financial performance and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $266.8 million | $256.7 million |
| Gross margin | 65.8% | 64.5% |
| Operating income | $12.4 million | $8.1 million |
| Net income | $12.1 million | $5.8 million |
| Diluted EPS | $0.39 | $0.18 |
| Adjusted EBITDA (non-GAAP) | $53.4 million | $52.7 million |
| Operating cash flow | $51.2 million | $42.4 million |
- Revenue grew 4%. Workforce Solutions revenue increased 4% to $213.6 million; Provider Solutions revenue increased 4% to $53.2 million. Acquisitions contributed $3.9 million, net of applicable deferred-revenue write-downs; legacy resuscitation revenue declined $3.4 million.
- Operating income rose 55%. The company attributed improvement to revenue growth, lower general and administrative expenses, and other factors. Adjusted EBITDA grew 1%, substantially slower than GAAP net income.
- Operating cash flow increased 21%, primarily due to higher collections; days sales outstanding improved to 46 from 50.
- Cash, cash equivalents, and marketable securities totaled $53.9 million. There was no debt outstanding, and the $65 million revolving facility was fully available. Working capital shifted from positive $6.5 million to negative $2.8 million, primarily reflecting higher deferred revenue, accrued liabilities—including $6.6 million related to eeds—and accounts payable.
- Cash used in investing activities was $28.4 million, including $23.3 million of capitalized software development payments. Cash used in financing was $23.7 million, principally $23.1 million of share repurchases.
Material changes, outlook, and risks
- Growth reflected subscription expansion and acquisitions, while professional-services revenue in Provider Solutions was lower and legacy resuscitation products continued to decline. The company completed the CloudCME acquisition in May 2022 and acquired eeds on December 31; the approximately $6.6 million eeds purchase price was paid in January 2023.
- Other income included a $2.7 million gain associated with the sale of a non-marketable equity investment and a $0.9 million gain from remeasuring the previously held CloudCME interest. These items benefited reported results and should be distinguished from ongoing operations.
- Management did not provide numerical 2023 revenue or earnings guidance in the supplied filing text. It said pandemic-related booking delays may continue to weigh on revenue and earnings in 2023, although to a lesser extent, and cited inflation, elevated interest rates, labor-market pressures, and customer spending uncertainty.
- The One HealthStream consolidation included eliminating 33 job roles in early 2023; management expected approximately $0.8 million in severance charges across the first and second quarters and anticipated operational efficiencies. The company also planned to consolidate branding and contracting and report one segment.
- On February 20, 2023, the board announced an intended quarterly dividend of $0.025 per share, with the first payment scheduled for April 28, 2023. The board may modify, suspend, or cancel the policy.
- Key risks include customer renewals and concentration, healthcare-sector spending and reimbursement pressures, competition, execution of platform consolidation and acquisitions, cybersecurity and privacy regulation, hiring and retention, and possible impairment of goodwill or investments. Management said current litigation was not expected to have a material adverse effect; Item 3 reported no legal proceedings, while the notes describe ordinary-course matters.
- The revolving credit facility matured October 28, 2023, after the balance-sheet date, making refinancing or extension status relevant to subsequent-period review. The company reported covenant compliance at December 31, 2022.
Investor facts to verify
- Confirm the composition and sustainability of FY2022 earnings growth, particularly the investment-related gains, and reconcile GAAP net income with adjusted EBITDA.
- Review the disclosed $517 million of remaining performance obligations, including expected recognition of approximately 44% during 2023, and assess cancellations, renewals, and implementation timing.
- Assess whether the single-segment transition delivers the projected efficiencies without disrupting customer service, and track the disclosed severance costs.
- Check the status of the revolving credit facility after its October 2023 maturity and the ongoing capacity to fund acquisitions, repurchases, and dividends.
- Review acquisition integration and purchase accounting for CloudCME and eeds. The auditor’s internal-control opinion was unqualified, but eeds was excluded from management’s and the auditor’s 2022 internal-control assessment because it was acquired at year-end.